SG10201602384VA - Perfluorinated compounds for the non-viral transfer of nucleic acids - Google Patents

Perfluorinated compounds for the non-viral transfer of nucleic acids

Info

Publication number
SG10201602384VA
SG10201602384VA SG10201602384VA SG10201602384VA SG10201602384VA SG 10201602384V A SG10201602384V A SG 10201602384VA SG 10201602384V A SG10201602384V A SG 10201602384VA SG 10201602384V A SG10201602384V A SG 10201602384VA SG 10201602384V A SG10201602384V A SG 10201602384VA
Authority
SG
Singapore
Prior art keywords
nucleic acids
viral transfer
perfluorinated compounds
perfluorinated
compounds
Prior art date
Application number
SG10201602384VA
Inventor
Konstanze Schäfer
Original Assignee
Konstanze Schäfer
Libera Körner Jeanette
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Konstanze Schäfer, Libera Körner Jeanette filed Critical Konstanze Schäfer
Publication of SG10201602384VA publication Critical patent/SG10201602384VA/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/52—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an inorganic compound, e.g. an inorganic ion that is complexed with the active ingredient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/0002—General or multifunctional contrast agents, e.g. chelated agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Inorganic Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Molecular Biology (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Saccharide Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
SG10201602384VA 2011-03-31 2012-03-29 Perfluorinated compounds for the non-viral transfer of nucleic acids SG10201602384VA (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DE102011016334 2011-03-31
DE102011101361 2011-05-09
DE102011112191 2011-08-26
DE102011117390 2011-10-20

Publications (1)

Publication Number Publication Date
SG10201602384VA true SG10201602384VA (en) 2016-05-30

Family

ID=45974266

Family Applications (3)

Application Number Title Priority Date Filing Date
SG10202010626PA SG10202010626PA (en) 2011-03-31 2012-03-29 Perfluorinated compounds for the non-viral transfer of nucleic acids
SG10201602384VA SG10201602384VA (en) 2011-03-31 2012-03-29 Perfluorinated compounds for the non-viral transfer of nucleic acids
SG2013073242A SG194013A1 (en) 2011-03-31 2012-03-29 Perfluorinated compounds for the non-viral transfer of nucleic acids

Family Applications Before (1)

Application Number Title Priority Date Filing Date
SG10202010626PA SG10202010626PA (en) 2011-03-31 2012-03-29 Perfluorinated compounds for the non-viral transfer of nucleic acids

Family Applications After (1)

Application Number Title Priority Date Filing Date
SG2013073242A SG194013A1 (en) 2011-03-31 2012-03-29 Perfluorinated compounds for the non-viral transfer of nucleic acids

Country Status (8)

Country Link
US (2) US20140065223A1 (en)
EP (1) EP2691118B1 (en)
JP (1) JP2014510743A (en)
CN (1) CN103764169B (en)
AU (1) AU2012234259A1 (en)
CA (1) CA2830324A1 (en)
SG (3) SG10202010626PA (en)
WO (1) WO2012130941A2 (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9303079B2 (en) 2012-04-02 2016-04-05 Moderna Therapeutics, Inc. Modified polynucleotides for the production of cytoplasmic and cytoskeletal proteins
AU2013243953A1 (en) 2012-04-02 2014-10-30 Modernatx, Inc. Modified polynucleotides for the production of nuclear proteins
US9283287B2 (en) 2012-04-02 2016-03-15 Moderna Therapeutics, Inc. Modified polynucleotides for the production of nuclear proteins
US9136377B2 (en) * 2013-03-11 2015-09-15 Alpha & Omega Semiconductor, Inc. High density MOSFET array with self-aligned contacts delimited by nitride-capped trench gate stacks and method
WO2017186711A1 (en) 2016-04-25 2017-11-02 Invivogen Novel complexes of immunostimulatory compounds, and uses thereof
CN106187981B (en) * 2016-07-11 2018-04-03 中国科学院生态环境研究中心 A kind of perfluoroalkyl acid probe of fluorescence labeling and its application
WO2019042888A1 (en) * 2017-08-27 2019-03-07 Caperis Gmbh Perfluorinated nucleic acids used as surfactants with specific properties
CN113924309A (en) * 2019-05-21 2022-01-11 株式会社纳蒂亚斯 Polyfluoro block polymers for use in oligonucleotide synthesis and methods of oligonucleotide synthesis using same
JPWO2021060506A1 (en) * 2019-09-27 2021-04-01
WO2022186350A1 (en) 2021-03-03 2022-09-09 国立大学法人東京大学 Acyclic threoninol nucleic acid
CN114933565A (en) * 2022-05-12 2022-08-23 深圳厚存纳米药业有限公司 Nucleobase derivative nanoparticles and composition thereof
CN115368575B (en) * 2022-10-25 2023-01-13 山东华夏神舟新材料有限公司 Water-repellent and oil-repellent fabric finishing agent, finishing agent stock solution and preparation method thereof

Family Cites Families (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5663966A (en) * 1979-10-29 1981-05-30 Tokyo Kinzoku Kogyo Kk Pyrimidine derivative and its preparation
JPS63188696A (en) * 1987-01-29 1988-08-04 Sumitomo Chem Co Ltd Production of 5-(perfluoroalkyl)uridine derivative
FR2640629B1 (en) * 1988-12-20 1991-02-08 Merieux Inst NOVEL DEOXY-2 RIBONUCLEOSIDES DERIVATIVES, PROCESS FOR THEIR PREPARATION AND THEIR APPLICATIONS
US5703055A (en) 1989-03-21 1997-12-30 Wisconsin Alumni Research Foundation Generation of antibodies through lipid mediated DNA delivery
US6214804B1 (en) 1989-03-21 2001-04-10 Vical Incorporated Induction of a protective immune response in a mammal by injecting a DNA sequence
JPH04117366A (en) * 1990-09-06 1992-04-17 Nippon Oil & Fats Co Ltd Polyfluoroalkyl group-containing pyrimidine derivative and production thereof
JP3032781B2 (en) * 1990-09-06 2000-04-17 工業技術院長 Method for producing pyrimidine derivative containing fluoroalkyl group
JPH04352769A (en) * 1990-09-12 1992-12-07 Nippon Oil & Fats Co Ltd Fluoroalkyl group-containing uracil derivative and production thereof
JPH04149193A (en) * 1990-10-15 1992-05-22 Nippon Oil & Fats Co Ltd Fluoroalkyl-containing uridine derivative and its production
JP3047077B2 (en) * 1990-10-15 2000-05-29 工業技術院長 Method for producing fluoroalkyl group-containing uridine derivative
JPH04257565A (en) * 1991-02-08 1992-09-11 Nippon Oil & Fats Co Ltd Polyfluoroalkyl group-containing pyrimidine derivative and its production
JP3032837B2 (en) * 1991-02-14 2000-04-17 工業技術院長 Fluoroalkyl group-containing pyrimidine derivative and method for producing the same
JP3086912B2 (en) * 1991-06-20 2000-09-11 工業技術院長 Fluoroalkyl group-containing purine derivative and method for producing the same
HUP9900879A2 (en) * 1995-06-07 1999-08-30 Alliance Pharmaceutical Corp. Reverse fluorocarbon emulsion compositions for drug delivery
EP2292771A3 (en) 1997-09-19 2011-07-27 Life Technologies Corporation Sense mRNA therapy
JP4160645B2 (en) * 1997-12-24 2008-10-01 大日本住友製薬株式会社 Novel adenine derivatives and their pharmaceutical use
JP4162840B2 (en) * 1999-08-20 2008-10-08 セケラ インコーポレイテッド New A-50039 derivative
JP4658438B2 (en) * 2001-02-19 2011-03-23 セケラ インコーポレイテッド Antibacterial agent containing novel A-50039 derivative
EP2305699B1 (en) 2001-06-05 2014-08-13 CureVac GmbH Stabilised mRNA with increased G/C content which is optimised for translation in its coded areas for the vaccination against sleeping sickness, leishmaniosis and toxoplasmosis
JP2003116581A (en) * 2001-10-18 2003-04-22 Dna Chip Kenkyusho:Kk Labeled nucleic acid and method for producing the same
WO2003062198A1 (en) * 2002-01-24 2003-07-31 Barnes Jewish Hospital Integrin targeted imaging agents
NZ536123A (en) * 2002-05-06 2006-09-29 Genelabs Tech Inc Nucleoside derivatives for treating hepatitis C virus infection
FR2846969A1 (en) * 2002-11-08 2004-05-14 Salles Jean Pierre New modified active agent derivatives with improved bioavailability comprising parent drug, e.g. anticancer agent, plus fluorinated hydrocarbon chain and recognition or hydrophilizing moiety
JP4945129B2 (en) * 2004-01-27 2012-06-06 株式会社キラルジェン Fluorous carrier and method for producing oligonucleotide derivative using the same
FR2869616B1 (en) * 2004-04-29 2008-10-24 Univ D Avignon Et Des Pays Du NOVEL AMPHIPHILIC COMPOUNDS, PROCESS FOR THEIR PREPARATION AND THEIR APPLICATIONS IN PARTICULAR FOR TRANSFECTION
US20060178507A1 (en) * 2004-12-30 2006-08-10 Berry & Associates, Inc. Fluorous oligonucleotide reagents and affinity purification of oligonucleotides
JP5053622B2 (en) * 2005-11-09 2012-10-17 東ソー株式会社 Nucleobase having a perfluoroalkyl group and method for producing the same
JP5320284B2 (en) * 2006-05-03 2013-10-23 キメリクス，インコーポレーテッド Metabolically stable alkoxyalkyl esters of antiviral or antiproliferative phosphonates, nucleoside phosphonates and nucleoside phosphates
US20100016409A1 (en) 2006-06-02 2010-01-21 Government Of The Us, As Represented By The Secretary, Department Of Health And Human Services Rna Nanoparticles and Nanotubes
CA2654375A1 (en) * 2006-06-27 2008-01-03 Biovitrum Ab (Publ) Therapeutic compounds
JP5090711B2 (en) * 2006-11-06 2012-12-05 東ソー株式会社 Process for producing 2,6-diamino-8,8-bis (perfluoroalkyl) -8H-purines
EP2170888B1 (en) * 2007-06-29 2015-04-22 Gilead Sciences, Inc. Purine derivatives and their use as modulators of toll-like receptor 7
TWI437994B (en) * 2007-09-17 2014-05-21 Abbvie Bahamas Ltd Anti-infective agents and uses thereof
EP2123256A1 (en) * 2008-05-19 2009-11-25 Ruhr-Universität Bochum Perfluorcarbon nanoemulsions with endocytosis enhancing surface for gene-transfer
CA2726579C (en) * 2008-06-03 2015-02-17 Taiho Pharmaceutical Co., Ltd. Novel uracil compound or salt thereof having human deoxyuridine triphosphatase inhibitory activity
GB0813042D0 (en) * 2008-07-16 2008-08-20 Syngenta Participations Ag Insecticidal compounds
CN102762698B (en) * 2010-02-18 2014-10-22 国际壳牌研究有限公司 Tubular wall assembly and gasification reactor
US8895737B2 (en) * 2010-07-16 2014-11-25 Shashank Shekhar Process for preparing antiviral compounds

Also Published As

Publication number Publication date
WO2012130941A2 (en) 2012-10-04
US20190382790A1 (en) 2019-12-19
CN103764169B (en) 2017-06-13
EP2691118A2 (en) 2014-02-05
CA2830324A1 (en) 2012-10-04
JP2014510743A (en) 2014-05-01
WO2012130941A3 (en) 2013-01-03
AU2012234259A1 (en) 2013-10-03
SG10202010626PA (en) 2020-11-27
CN103764169A (en) 2014-04-30
SG194013A1 (en) 2013-11-29
US20140065223A1 (en) 2014-03-06
EP2691118B1 (en) 2019-05-01

Similar Documents

Publication Publication Date Title
SG10202010626PA (en) Perfluorinated compounds for the non-viral transfer of nucleic acids
HK1198479A1 (en) Methods for the synthesis of functionalized nucleic acids
HK1201077A1 (en) Sequencing small amounts of complex nucleic acids
AP3913A (en) D-amino acid compounds for liver disease
EP2707510A4 (en) Isolation of nucleic acids
HUE056246T2 (en) Compositions for nucleic acid sequencing
IL236685A0 (en) Chiral nucleic acid adjuvant
EP2673380A4 (en) Analysis of nucleic acids
EP2729182A4 (en) Nucleic acid complex
EP2694683A4 (en) CONFORMATIONALLY-PREORGANIZED, MiniPEG-CONTAINING GAMMA-PEPTIDE NUCLEIC ACIDS
EP2778454A4 (en) Fixed constant-velocity universal joint
SG11201400939YA (en) Process for the preparation of methoxymelonal
EP2700414A4 (en) Self-gelatinizable nucleic acid
FR2980795B1 (en) PROCESS FOR THE PREPARATION OF CATIONIC GALACTOMANNANES
EP2778452A4 (en) Fixed constant-velocity universal joint
IL231645A0 (en) Process for the preparation of isoxazolyl-methoxy-nicotinic acids
EP2682462A4 (en) (nucleic acid)-polysaccharide complex
HK1186172A1 (en) Process for the preparation of enolate salts of 4-fluoro-2-hydroxymethylene-3-oxo-butyrates 4--2-3-
SG11201400090UA (en) Process for the preparation of olefins
GB201119690D0 (en) Process for the preparation of compounds
PL393916A1 (en) Process for the preparation of carbapenemic compounds
GB201107286D0 (en) Nucleic acid preparation
PT2673282T (en) Novel process for the preparation of dronic acids
SG11201400091XA (en) Process for the preparation of olefins
IL235730A0 (en) D-amino acid compounds for liver disease